ID: ALA4290002

Max Phase: Preclinical

Molecular Formula: C24H26O4

Molecular Weight: 378.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H]1[C@H](c2ccccc2)[C@H](C(=O)OC2CCCCC2)[C@H]1c1ccccc1

Standard InChI:  InChI=1S/C24H26O4/c25-23(26)21-19(16-10-4-1-5-11-16)22(20(21)17-12-6-2-7-13-17)24(27)28-18-14-8-3-9-15-18/h1-2,4-7,10-13,18-22H,3,8-9,14-15H2,(H,25,26)/t19-,20-,21-,22-/m0/s1

Standard InChI Key:  KVRPLCLCJWQZCI-CMOCDZPBSA-N

Associated Targets(Human)

Fatty acid binding protein muscle 214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fatty acid binding protein epidermal 323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fatty acid-binding protein, brain 49 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 378.47Molecular Weight (Monoisotopic): 378.1831AlogP: 4.76#Rotatable Bonds: 5
Polar Surface Area: 63.60Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.41CX Basic pKa: CX LogP: 5.01CX LogD: 2.13
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.76Np Likeness Score: 0.40

References

1. Yan S, Elmes MW, Tong S, Hu K, Awwa M, Teng GYH, Jing Y, Freitag M, Gan Q, Clement T, Wei L, Sweeney JM, Joseph OM, Che J, Carbonetti GS, Wang L, Bogdan DM, Falcone J, Smietalo N, Zhou Y, Ralph B, Hsu HC, Li H, Rizzo RC, Deutsch DG, Kaczocha M, Ojima I..  (2018)  SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.,  154  [PMID:29803996] [10.1016/j.ejmech.2018.04.050]

Source